Hepatitis C virus (HCV) is the major cause of chronic liver disease worldwide. There is evidence that neutralizing anti-HCV antibodies may find potential applications in novel prophylactic and therapeutic strategies. This paper describes the very high neutralization activity and unique biological features of two broadly cross-reactive and cross-neutralizing anti-HCV human monoclonal IgG1 derived from human monoclonal recombinant Fab fragments.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
human monoclonal
12
neutralization activity
8
monoclonal igg1
8
igg1 derived
8
recombinant fab
8
fab fragments
8
hepatitis virus
8
activity kinetics
4
kinetics broad-range
4
broad-range human
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!